Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TOP1 | P11387 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 2/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19959870 | 0.94 | ALDH1A1 (0.33) | TOP1ALDH1A1HIF1ACYP1B1HSD17B10 | |
| SCHEMBL19959775 | 0.93 | TOP1 (0.37) | TOP1ALDH1A1NPSR1POLBLMNA | |
| SCHEMBL22166873 | 0.93 | TOP1 (0.34) | TOP1ALDH1A1HIF1ACYP1B1HSD17B10 | |
| SCHEMBL19959956 | 0.90 | TOP1 (0.38) | TOP1NPSR1POLBKDM4E | |
| SCHEMBL19959963 | 0.90 | TOP1 (0.39) | TOP1HSD17B10NPSR1POLBKDM4E | |
| SCHEMBL19959815 | 0.90 | POLB (0.33) | TOP1ALDH1A1POLBKDM4ELMNA | |
| SCHEMBL19959960 | 0.89 | TOP1 (0.38) | TOP1NPSR1POLBKDM4E | |
| SCHEMBL19959768 | 0.89 | TOP1 (0.40) | TOP1ALDH1A1HSD17B10NPSR1POLB | |
| SCHEMBL19959912 | 0.87 | NPSR1 (0.34) | TOP1ALDH1A1HIF1ACYP1B1HSD17B10 | |
| SCHEMBL19959961 | 0.86 | TOP1 (0.38) | TOP1NPSR1POLBKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10700289-B2 | Heterocyclic compound and organic light emitting element comprising same | LG CHEM, LTD. (KR) | 2020-06-30 | — | — | US | disclosed |
| US-20180076395-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2018-03-15 | — | — | US | disclosed |
| US-20180076395-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2018-03-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180076395-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME | CRY1, CRY2, PER2 | TOP1 2543/4885ALDH1A1 750/4885HIF1A 2027/4885 |
| US-10700289-B2 | Heterocyclic compound and organic light emitting element comprising same | CRY1, CRY2, PER2 | TOP1 2543/4885ALDH1A1 750/4885HIF1A 2027/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.